SERPINE1 and metabolic syndrome: As an important biomarker for disease, upregulation of the Plasminogen Activator Inhibitor-1 (PAI-1) has been linked to metabolic syndrome, obesity, inflammation, tissue fibrosis, and cardiovascular disease among others.